Nashville Biosciences
Jack Rowland has a diverse range of work experience. Jack started their career as a Rita's Server at Rita's Italian Ice from January 2010 to August 2012. In 2013, they worked as a Summer Intern at Peermusic and Kemado / Mexican Summer Records. Jack also served as a Research Assistant at Vassar College, assisting Prof. John McCleary, Prof. Kursad Tosun, and Prof. in their research projects from September 2013 to May 2015.
After that, Jack worked as a Teaching Assistant and Research Assistant at Columbia University Mailman School of Public Health from May 2016 to July 2016, and from September 2015 to May 2017, respectively. Jack then joined the Icahn School of Medicine at Mount Sinai as a Biostatistician I from May 2017 to May 2019.
Jack's next role was at Kantar Health, where they worked as a Biostatistician from May 2019 to June 2021, and later became a Senior Analyst from June 2021 to August 2021. Jack then joined CorEvitas, LLC as a Biostatistician III from September 2021 to June 2022. Currently, they are working at Nashville Biosciences as a Biostatistics Project & Program Manager starting from June 2022.
Jack Rowland completed their Bachelor of Arts degree in Mathematics at Vassar College from 2011 to 2015. Jack then pursued a Master of Science degree in Biostatistics at Columbia University Mailman School of Public Health from 2015 to 2017.
This person is not in any offices
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.